Genomics and life sciences pioneer J. Craig Venter, Ph.D., is back with a new J. | Genomics and life sciences pioneer J.

The CeliacDx offering for Texas marks the company’s first outreach to physicians with additional states planned for later this year. The expansion into physician-ordered testing furthers Targeted ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that PharosAI, a research consortium uniting four leading UK institutions, will use the 10x Genomics Xenium ...

REVEAL GENOMICS, S.L. is a Barcelona-based biotechnology company that discovers, develops, and markets innovative diagnostic ...

Droplet Digital TM PCR (ddPCR TM) has been an evolving tool for precision and absolute detection in genomics for over a ...

In January 2026, CareDx reported past-quarter revenue growth of 25% year over year and 14% for the full year, and announced a new collaboration with 10x Genomics to research transplant organ rejection ...

PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report ...

The past decade has delivered landmark advances in human and medical genomics that shape how we understand disease mechanisms ...

How CRISPR and functional genomics are used to establish causality, understand disease mechanisms and guide early drug ...

Spanish cancer biomarker medtech Reveal Genomics has boosted the roles of three of its founding members. | Spanish cancer biomarker medtech Reveal Genomics has boosted the roles of three of its ...

In a country where healthcare often begins after illness strikes, genomics is quietly changing the script. Speaking to Aditi ...

Learn more about whether Tempus AI, Inc. or 10x Genomics, Inc. is a better investment based on AAII's A+ Investor grades, ...